RCS - Kromek Group PLC - Kromek selected for UK Government Framework

KromekAnnouncement

30/07/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240730:nRSd2920Ya&default-theme=true

RNS Number : 2920Y  Kromek Group PLC  30 July 2024

30 July 2024

 

Kromek Group plc

("Kromek" or the "Group")

 

Kromek selected for UK Government Resilience Framework

First order received under the framework from Merseyside Fire & Rescue
Service

 

Kromek (AIM: KMK), a leading developer of radiation and bio-detection
technology solutions for the advanced imaging and CBRN detection segments, is
pleased to announce that its D3M detector has been named as the Personal
Radiation Detector ("PRD") under the UK Government Resilience Framework (the
"Framework"). The Group has received its first order under the Framework from
Merseyside Fire & Rescue Service, which will use the D3M for its
Detection, Identification and Monitoring ("DIM") vehicles.

 

The Framework is designed to strengthen the UK's resilience system to prevent
risks manifesting or crises happening where possible, addressing all serious
threats to public safety and security. It focuses on the foundational building
blocks of resilience, setting out a plan to 2030 to strengthen the frameworks,
systems and capabilities that underpin the UK's resilience to all civil
contingencies risks.

 

The D3M is the only PRD that has been pre-approved for purchase under the
Framework, which is scheduled to be in place for four years. As a result, all
blue light service operators in the UK, such as fire, police, ambulances and
first responders, can purchase the D3M detector for projects under the
Framework without going through a separate approval process.

 

Merseyside Fire & Rescue service have bought the D3M under their
Detection, Identification and Monitoring (DIM) Equipment Uplift project, which
involves acquiring equipment to enhance their capabilities for detection of
Chemical, Biological, Radiological, and Nuclear ("CBRN") threats.

 

Arnab Basu, CEO of Kromek, said: "We are delighted that our D3M detector has
been named as the only PRD under this significant UK initiative and to have
received our first order from Merseyside Fire & Rescue Service. The D3M is
a world-leading radiation detector that offers unprecedented situational
awareness. Being selected for this framework is another validation of the
strength of our solutions and opens up another important commercial avenue for
our CBRN products. We look forward to supporting Merseyside Fire & Rescue
Service and other emergency service operators in identifying potential
radiological threats and keeping people safe."

 

 

For further information, please contact:

 

 Kromek Group plc
 Arnab Basu, CEO                                                        +44 (0)1740 626 060

 Paul Farquhar, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Broker)        
 Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance            +44 (0)20 7220 0500

 Tim Redfern - ECM
 Michael Johnson/Tamar Cranford-Smith - Sales

 Gracechurch Group (Financial PR)
 Harry Chathli/Claire Norbury/Henry Gamble                              +44 (0)20 4582 3500

 

 

Kromek Group plc

 

Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.

 

The advanced imaging segment comprises the medical, security and industrial
markets. Kromek provides its OEM customers with detector components, based on
its core cadmium zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in industrial
manufacture and explosives in aviation settings.

 

In CBRN detection, the Group provides nuclear radiation detection solutions to
the global homeland defense and security market. Kromek's compact, handheld,
high-performance radiation detectors, based on advanced scintillation
technology, are primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty bombs'.

 

The Group is also developing bio-security solutions in the CBRN detection
segment. These consist of fully automated and autonomous systems to detect a
wide range of airborne pathogens.

 

Kromek is listed on AIM, a market of the London Stock Exchange, under the
trading symbol 'KMK'.

 

Further information is available at www.kromek.com (http://www.kromek.com/)
.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEAEXNADELEAA